T. Rowe Price Associates’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $307K | Buy |
|
|||||
|
2025
Q2 | $320K | Buy |
|
|||||
|
2025
Q1 | $242K | Buy |
|
|||||
|
2024
Q4 | $260K | Buy |
|
|||||
|
2024
Q3 | $237K | Buy |
|
|||||
|
2024
Q2 | $281K | Buy |
|
|||||
|
2024
Q1 | $284K | Buy |
|
|||||
|
2023
Q4 | $288K | Buy |
|
|||||
|
2023
Q3 | $275K | Buy |
|
|||||
|
2023
Q2 | $275K | Buy |
|
|||||
|
2023
Q1 | $267K | Sell |
|
|||||
|
2022
Q4 | $282K | Buy |
|
|||||
|
2022
Q3 | $286K | Buy |
|
|||||
|
2022
Q2 | $320K | Buy |
|
|||||
|
2022
Q1 | $291K | Buy |
|
|||||
|
2021
Q4 | $317K | Sell |
|
|||||
|
2021
Q3 | $349K | Buy |
|
|||||
|
2021
Q2 | $385K | Sell |
|
|||||
|
2021
Q1 | $438K | Sell |
|
|||||
|
2020
Q4 | $354K | Buy |
|